Immune-Based Drug Shows Promise Against Advanced Lung Cancer
Patients given nivolumab reported fewer side effects, longer survival than those receiving usual chemo agentContinue Reading
Patients given nivolumab reported fewer side effects, longer survival than those receiving usual chemo agentContinue Reading
Finding might one day help doctors better choose patients to receive Keytruda, study saysContinue Reading
Research suggests risk of nighttime breathing problem rises with severity of post-traumatic stress disorderContinue Reading
Labs interpret findings differently, perhaps leading to inappropriate ‘treatment’Continue Reading
Labs interpret findings differently, perhaps leading to inappropriate ‘treatment’Continue Reading
But those with three or four heart risk factors may benefit from getting beta-blockersContinue Reading
Researchers used harmless strain of E. coli to find metastatic disease in miceContinue Reading
Study finds widespread changes using specialized MRIContinue Reading
Study shows it helped a minority of patients, and experts say this approach has promiseContinue Reading
Experimental treatment might benefit people who forget to take meds, researcher saysContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.